|1.||Shichijo, Shigeki: 2 articles (12/2003 - 02/2003)|
|2.||Itoh, Kyogo: 2 articles (12/2003 - 02/2003)|
|3.||Maeda, Yoshiaki: 2 articles (12/2003 - 02/2003)|
|4.||Lim, H W: 1 article (11/2010)|
|5.||Hiremagalore, R: 1 article (11/2010)|
|6.||Elder, J T: 1 article (11/2010)|
|7.||Nair, R P: 1 article (11/2010)|
|8.||Kullavanijaya, P: 1 article (11/2010)|
|9.||Stuart, P E: 1 article (11/2010)|
|10.||Tejasvi, T: 1 article (11/2010)|
02/15/2003 - "These peptide-induced CTLs did not react to either HLA-B46(+) tumor cells without the p53 mutation or to HLA-B46(+) phytohemagglutinin-blastoid cells. "
02/15/2003 - "These results provide a scientific basis for the development of p53-directed specific immunotherapy for HLA-B46(+) cancer patients."
12/01/2003 - "The objective of this study was to identify novel genes and peptides capable of inducing tumor-reactive cytotoxic T lymphocytes (CTLs) in cancer patients with an HLA-B46 allele, which is preferentially expressed in Asians. "
|2.||Psoriasis (Pustulosis Palmaris et Plantaris)
11/01/2010 - "No association was seen in Thai HLA-Cw1 haplotypes lacking HLA-B46, nor was HLA-Cw1 associated with psoriasis in a large Caucasian sample. "
11/01/2010 - "Earlier studies have shown that psoriasis in Japan and Thailand is associated with two different major histocompatibility complex (MHC) haplotypes - those bearing HLA-Cw6 and those bearing HLA-Cw1 and HLA-B46. "
02/01/2005 - "Our results revealed that the allele frequencies of HLA-B46, -B56, and -DRB1*1001 were statistically different between non-cerebral severe malaria and cerebral malaria (P = 0.005), between mild malaria and cerebral malaria (P = 0.032), and between mild malaria and non-cerebral malaria (P = 0.007). "
|4.||BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)